SereNeuro Therapeutics

www.sereneuro.com
1812 Ashland Avenue
Baltimore, MD 21205-1546

Company Info

Year Established
2024

Contacts

Dan Saragnese, MBA
Co-Founder & CEO

Company Description

Deciphering the functional heterogeneity of human pain perception and developing advanced therapies for non-opioid pain relief.